RTW INVESTMENTS, LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$52,433,000
+1.3%
582,265
+10.0%
0.77%
-65.6%
Q1 2020$51,772,000
-33.8%
529,261
-12.6%
2.23%
-24.4%
Q4 2019$78,168,000
+43.3%
605,762
-16.4%
2.95%
-9.1%
Q3 2019$54,555,000
-40.6%
724,311
+19.9%
3.24%
-33.8%
Q2 2019$91,814,000
+127.8%
604,236
+78.7%
4.90%
+78.2%
Q1 2019$40,310,000
+0.9%
338,199
-7.6%
2.75%
-26.0%
Q4 2018$39,932,000
-21.3%
365,911
+16.5%
3.72%
+22.4%
Q3 2018$50,725,000
-60.8%
314,070
-67.9%
3.04%
-67.4%
Q2 2018$129,345,000
+153.6%
978,551
+42.2%
9.33%
+92.2%
Q1 2018$50,994,000688,2714.85%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders